MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2407
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer ; volume:14 ; number:1 ; day:18 ; month:11 ; year:2014 ; pages:1-10 ; date:12.2014
BMC cancer ; 14, Heft 1 (18.11.2014), 1-10, 12.2014

Creator
Pénzváltó, Zsófia
Contributor
Lánczky, András
Lénárt, Julianna
Meggyesházi, Nóra
Krenacs, Tibor
Szoboszlai, Norbert
Denkert, Carsten
Pete, Imre
Győrffy, Balázs
SpringerLink (Online service)

DOI
10.1186/1471-2407-14-837
URN
urn:nbn:de:1111-2016030416452
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Pénzváltó, Zsófia
  • Lánczky, András
  • Lénárt, Julianna
  • Meggyesházi, Nóra
  • Krenacs, Tibor
  • Szoboszlai, Norbert
  • Denkert, Carsten
  • Pete, Imre
  • Győrffy, Balázs
  • SpringerLink (Online service)

Other Objects (12)

Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer

Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer

SPON1 is an independent prognostic biomarker for ovarian cancer

SPON1 is an independent prognostic biomarker for ovarian cancer

Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer

Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer

Carboplatin-induced gene expression changes in vitroare prognostic of survival in epithelial ovarian cancer

Carboplatin-induced gene expression changes in vitroare prognostic of survival in epithelial ovarian cancer

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

Engrailed-2 (EN2) – a novel biomarker in epithelial ovarian cancer

Engrailed-2 (EN2) – a novel biomarker in epithelial ovarian cancer

Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells

Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells

Serum-based N-glycan biomarker for diagnosis of epithelial ovarian cancer. The ascites N-glycome of epithelial ovarian cancer.

Hochschulschrift

Serum-based N-glycan biomarker for diagnosis of epithelial ovarian cancer. The ascites N-glycome of epithelial ovarian cancer.

APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer

APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer

Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer

Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer

CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival

CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival

CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients

CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients

Related objects